Capstone Investment Advisors
CORT icon

Capstone Investment Advisors’s Corcept Therapeutics CORT Stock Holding History

Capstone Investment Advisors’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5,476
Closed -$402K – 1944
2025
Q2 		$402K Buy
+5,476
New +$397K ﹤0.01% 1244
2025
Q1 		– Sell
-8,862
Closed -$447K – 1455
2024
Q4 		$447K Sell
8,862
-9,964
-53% -$522K ﹤0.01% 1346
2024
Q3 		$871K Buy
+18,826
New +$669K 0.02% 1001
2023
Q4 		– Sell
-7,367
Closed -$201K – 2157
2023
Q3 		$201K Buy
+7,367
New +$213K 0.01% 1811
2017
Q1 		– Sell
-29,000
Closed -$210K – 929
2016
Q4 		$210K Buy
+29,000
New +$227K 0.01% 811

Other funds holding CORT

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.82B AUM 21.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.55B AUM 17.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return